Does Retatrutide Cause Hair Loss?
The short answer is that hair loss has been reported by some GLP-1 drug users, but it is not a direct pharmacological effect of retatrutide or any other drug in the class. The hair loss that occurs is most likely telogen effluvium — a temporary shedding of hair triggered by rapid weight loss, nutritional changes, or physiological stress. It is the same phenomenon that can occur after pregnancy, major surgery, or significant caloric restriction. The distinction matters because it changes how the problem should be addressed.
What the Clinical Trial Data Shows
Hair loss was not reported as a frequent adverse event in the retatrutide Phase 2 trial published in the New England Journal of Medicine in 2023. The adverse event tables listed typical GLP-1 effects — nausea, diarrhea, constipation, vomiting — but did not list alopecia or hair loss as occurring at rates above placebo. In the broader GLP-1 clinical literature, some tirzepatide and semaglutide trials have reported hair loss rates of 2-5%, but these rates are not consistently higher than placebo and are generally attributed to weight loss rather than the drug itself.
The Mechanism: Why Rapid Weight Loss Can Cause Hair Shedding
Telogen effluvium occurs when a physiological stressor pushes a large number of hair follicles from the growth phase (anagen) into the resting phase (telogen) simultaneously. About 2 to 4 months later, those hairs shed as the follicles re-enter the growth phase. Rapid weight loss of 20 pounds or more over a few months is a well-established trigger. The weight loss produced by retatrutide — 28.3% average at 80 weeks in the TRIUMPH-1 trial — is significant enough that some degree of telogen effluvium is expected in a subset of users, regardless of which drug produced the weight loss.
What to Do If You Experience Hair Loss
If hair shedding occurs while using retatrutide, the first step is to ensure adequate protein intake. GLP-1 drugs reduce appetite, which can lead to insufficient protein consumption. Protein intake of at least 1.2 grams per kilogram of body weight per day supports hair follicle function. Supplementing with iron, zinc, and vitamin D — if blood levels are low — can also help. The hair loss is almost always temporary. Full regrowth typically occurs over 6 to 12 months as the hair follicles cycle back into the growth phase.
When to Be Concerned
Hair loss that continues beyond 6 months, that is patchy rather than diffuse, or that occurs without significant weight loss may have a cause unrelated to retatrutide and should be evaluated by a healthcare provider. Thyroid dysfunction, iron deficiency, and autoimmune conditions can all cause hair loss and should be ruled out. The clinical trial data does not suggest that retatrutide itself damages hair follicles or causes permanent hair loss. The weight loss it produces can trigger temporary shedding, but the hair grows back.
Leave a Reply